Time from Migraine Onset to Surgery Predicts Postoperative Headache Frequency: A Retrospective Cohort Study
Abstract
Background: Migraine trigger-site surgery has been proposed for medically refractory migraine, yet predictors of postoperative outcome remain incompletely defined. The influence of the interval between migraine onset and surgical intervention has not been systematically evaluated.
Methods: A retrospective cohort study of consecutive patients undergoing migraine trigger-site surgery in Taiwan (2019-2024) was conducted. The primary endpoint was postoperative headache frequency per month; Migraine Headache Index (MHI) was the secondary endpoint. Time-to-surgery (years from migraine onset to operation) was evaluated using Spearman correlation, group comparison, and multivariable regression adjusted for age, sex, preoperative frequency, trigger-site number, and nerve block status.
Results: Among 54 patients (70.4% female; mean age 38.0 years), 47 (87.0%) achieved successful treatment (≥50% frequency reduction) and 16 (29.6%) achieved frequency elimination. Median time-to-surgery was 15 years. Longer time-to-surgery was significantly correlated with higher postoperative frequency (Spearman ρ = 0.397; p = 0.003) and remained an independent predictor in multivariable regression (β = 0.342; 95% CI 0.107-0.577; p = 0.005), alongside preoperative frequency (β = 0.270; p = 0.011). Patients with time-to-surgery at or below the cohort median (15 years) achieved a 96% success rate with 43% complete elimination, compared with 77% success and 15% elimination among those with longer durations…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 54 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.